HollisterStier grows mites in our own facilities according to our exacting standards, allowing us to control the product at every step of the process. Our manufacturing plant is regulated by both CBER and CDER.
Effective diagnosis and treatment mean you reach and benefit more patients. Studies have shown that puncture skin testing with D. farinae at 30,000 AU/mL identified more than twice as many mite sensitive patients when compared to 10,000 AU/mL.1 We offer both to give you more options.
Available in 10,000 AU/mL and 30,000 AU/mL to help you meet immunotherapy guidelines.
Also available in a variety of vial sizes, meaning you can match both strength and size to best meet your needs.
Like all of our glycerinated antigens, our mite doesn’t contain phenol…which can denature the proteins in allergenic extracts.2
| ITEM NO. | DESCRIPTION | CONCENTRATION |
| 6691 | Standardized 50/50 Mite Mix, D. pteronyssinus and D. farinae | 5,000 AU/mL (each species) or 15,000 AU/mL (each species) |
| 6692 | Standardized Mite, D. pteronyssinus | 10,000 AU/mL or 30,000 AU/mL |
| 6720 | Standardized Mite, D. farinae | 10,000 AU/mL or 30,000 AU/mL |
Footnotes
1J. Jones and N. Wallen. Comparison of puncture skin test (PST) reactivity to standardized D. farina (DF) extracts at 30,000 AU/ml (30k) and 10,000 AU/mL (10k). AAAI, March 1991.
2 H.S. Nelson. Preparing and mixing allergen vaccines for subcutaneous immunotherapy.